In addition, IL-19 administration also reduced ischemia-induced brain infarct and neurological deficits in mice after experimental ischemic stroke, indicating that IL-19 is a novel therapeutic target for cerebral I/R injury [37]. Here, IL19 is linked to brain infarction.